Women demand the use of dolutegravir at the 2018 International Aids Conference CREDIT: GARETH FULLER/PA
The benefits of a landmark treatment for HIV outweigh the risks, despite the fact it has been linked to birth defects in babies born to mothers taking the drug, researchers have said. Read More
